Ruijin Hospital
Clinical trials sponsored by Ruijin Hospital, explained in plain language.
-
Blood test could prevent deadly virus in transplant patients
Disease control OngoingThis study aims to see if a blood test that measures the immune system's strength against a common virus (CMV) can help doctors decide how long to give a preventive antiviral drug. It involves 250 adults who have received a stem cell transplant for blood cancer. The goal is to be…
Phase: PHASE3 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hepatitis b treatment trial targets silent virus carriers
Disease control OngoingThis study is testing whether the drug TMF can safely control Hepatitis B virus in people who have normal liver enzyme levels. Researchers are enrolling 200 patients who have never received treatment before to see if TMF reduces virus levels and prevents liver damage. The trial c…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New cancer drug enters human testing for advanced tumors
Disease control OngoingThis is an early-stage clinical trial to test a new drug called CS01 in patients with advanced solid tumors that have spread. The main goals are to find a safe dose, check for side effects, and see if the drug shows any early signs of helping to shrink tumors. The study will enro…
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
CAR-T therapy shows promise against tough leukemia in real patients
Disease control OngoingThis study looks back at how well CNCT-19 CAR-T cell therapy worked for 275 Chinese adults with B-cell acute lymphoblastic leukemia. Researchers are checking how many patients responded to treatment, how long remissions lasted, and what side effects occurred. The goal is to under…
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug combo tested to fight stomach cancer before surgery
Disease control OngoingThis trial is testing whether adding two newer drugs (apatinib and camrelizumab) to standard chemotherapy helps people with advanced stomach cancer. The treatment is given both before and after surgery. The goal is to see if this combination can better shrink the tumor before sur…
Phase: PHASE2, PHASE3 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New tech aims to see inside lungs to save ARDS patients
Disease control ENROLLING_BY_INVITATIONThis study is testing a new bedside imaging technology called Electrical Impedance Tomography (EIT) to help doctors better manage ventilator settings for patients with severe ARDS. By creating real-time pictures of air and blood flow in the lungs, researchers hope to find the saf…
Phase: PHASE2, PHASE3 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New heart surgery strategy aims to cut major complications
Disease control OngoingThis study aims to find the best way to decide which clogged heart arteries to fix during planned heart valve surgery. It compares a newer computer-based measurement (QFR) against the standard visual method to guide surgeons. The goal is to see if the newer method can better prev…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Brain zaps tested as last hope for untreatable depression
Disease control OngoingThis study is testing a personalized brain stimulation treatment for people with severe depression that hasn't improved with standard medications. Ten participants with special research electrodes already implanted in their brains will receive both real and fake stimulation in ra…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New drug combo trial aims to shrink tumors before stomach cancer surgery
Disease control OngoingThis study is testing whether giving patients with advanced stomach or gastroesophageal cancer a combination of immunotherapy and chemotherapy drugs before surgery can help shrink their tumors. The goal is to see if this 'pre-surgery' treatment makes the subsequent operation more…
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
One-Week radiation blitz tested for breast cancer
Disease control OngoingThis study is testing a much shorter, one-week radiation schedule for breast cancer patients who need treatment to the breast area and nearby lymph nodes. It aims to see if this faster approach is as effective as standard, longer courses at controlling cancer while checking for s…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
New hope for patients with untamable inflammatory disease
Disease control OngoingThis study is testing if a drug called sirolimus can help control the severe inflammation and symptoms of Adult-Onset Still's Disease (AOSD) in patients who haven't improved with standard steroid treatments. It will involve just three patients with this rare, difficult-to-treat c…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC
-
Drug combo trial aims to prevent heart bypass failures
Disease control TerminatedThis study wanted to test whether taking two common blood pressure medications after heart bypass surgery could help keep the new artery grafts from closing up. The trial planned to compare patients taking the medications for 24 weeks against those not taking them, checking graft…
Phase: PHASE4 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC
-
New scan could warn doctors before breathing treatment fails
Diagnosis OngoingThis study tested a special imaging scan called Electrical Impedance Tomography (EIT) to see if it could predict when a common oxygen therapy for breathing failure would stop working. Researchers monitored 90 adult patients in China who were receiving oxygen through a high-flow n…
Sponsor: Ruijin Hospital • Aim: Diagnosis
Last updated Apr 01, 2026 14:43 UTC
-
New scan aims to pinpoint dangerous heart blockages
Diagnosis OngoingThis study is testing how well a new, detailed ultrasound scan (called UFR) can identify serious blockages in heart arteries. It compares the new scan's results to a standard diagnostic method in 112 patients with suspected heart disease. The goal is to see if this new imaging te…
Sponsor: Ruijin Hospital • Aim: Diagnosis
Last updated Mar 06, 2026 15:37 UTC
-
Can a drug stop a sleep disorder from turning into Parkinson's?
Prevention OngoingThis study is testing if the drug Idebenone can safely delay or prevent people with a specific sleep disorder (iRBD) from developing serious brain diseases like Parkinson's. About 142 participants will take either Idebenone or a placebo for five years. Researchers will track whet…
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Prevention
Last updated Mar 31, 2026 12:11 UTC
-
Zapping the brain to ease Parkinson's shakes
Symptom relief ENROLLING_BY_INVITATIONThis study is testing whether a non-invasive brain stimulation technique called temporal interference stimulation (tTIS) can improve movement symptoms in people with early to mid-stage Parkinson's disease. Researchers will compare stimulation of two different brain areas to see w…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
Scientists hunt for sepsis clues in Patients' blood
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand how a specific gene, called TRIM25, behaves in the blood cells of people with sepsis compared to those without it. Researchers will collect blood samples from about 65 hospitalized patients to see if the activity of this gene is linked to how well pa…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
New scoring system aims to level the playing field for stomach cancer surgery
Knowledge-focused OngoingThis study is creating a new tool, called the SAH Index, to fairly compare how well different hospitals perform stomach cancer surgery. It uses existing medical records from 780 patients who had surgery in 2019 to account for differences in patient health before their operation. …
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Scientists track lung blood flow to predict ARDS survival
Knowledge-focused OngoingThis study aims to understand if tracking how blood flows through the lungs of patients with severe ARDS can help predict their chances of survival. Researchers will use a special belt placed around the chest to take daily, non-invasive pictures of lung blood flow in 120 patients…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC
-
Doctors review past cases to gauge cancer Drug's impact
Knowledge-focused OngoingThis study is looking back at the medical records of 102 adults with a type of blood cancer called B-cell acute lymphoblastic leukemia (B-ALL). Researchers want to understand how well and how safely the drug inotuzumab ozogamicin worked for these patients in real-world settings. …
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:07 UTC